Telexcell Trade Eyes 25% Stake in Welcure Drugs to Expand Global Reach
Published on: Sept. 3, 2025, 6:06 p.m. | Source: Devdiscourse
Welcure Drugs & Pharmaceuticals Ltd is set to receive a significant investment from Singapore-based Telexcell Trade, which plans to acquire a 25% equity stake at Rs 20 per share. This strategic move aims to enhance Welcure's international presence and involves a funding initiative for an agro-pharma research lab.
